In both trials the primary endpoint is improvement in fibrosis by 1 stage without worsening of NASH.[101], [102] Combination therapies Key Point It is likely that combining therapies that engage different targets may provide a synergistic histopathologic benefit
A study published in the Journal of the American Medical Association last month shows that although patients achieved a statistically significant degree of average weight loss of 3.7% one year after starting on medications, the overall reported magnitude of benefit was less than in reported trials
Trico D, Nesti L, Frascerra S, Baldi S, Mengozzi A, Natali A
However, there is no proof that chelation therapy is effective for behavioral disorders such as autism
Consider seeking medical advice if the following occurs: Sudden, intense sweating that regularly soaks clothing or bedding